Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2708 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Vitae Pharmaceuticals names new CFO

Ms Fiumenero joined Vitae in January 2006 as senior vice president of finance and administration. Prior to joining Vitae Pharmaceuticals, Ms Fiumenero has spent 13 years at Bristol-Myers

Patheon opens new PDS suite in Canada

The suite includes a designated area for the small-scale development and manufacturing of solid dosage forms for customers’ early clinical study needs. The 2,500sqft suite is designed to

Addrenex initiates Phase II hypertension trial

The Phase II trial is a multicenter, double-blind, placebo-controlled, dose-ranging study that will involve 80 patients. ADX415 is a novel, patented, centrally acting, alpha-adrenergic receptor agonist specific to

Arginetix raises $2.3 million in financing

The financing was co-led by Quaker BioVentures and MedImmune Ventures. Other investors included Red Abbey Venture Partners, Maryland Health Care Product Development Corporation and Acidophil. The company said